In this study, participants using semaglutide had a lower risk for CVD-related events when compared with placebo.38 These results build on prior evidence that GLP-1s not only support blood sugar and weight management but also offer significant cardiovascular protection in high-risk populations.39 A 2021 systematic review published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews examined six studies involving over 182,000 adults with T2DM to evaluate the cardioprotective effects of GLP-1s (primarily liraglutide and exenatide) taken in conjunction with blood pressure and cholesterol lowering medications.40 The findings showed consistent improvements in cardiac function, including increased left ventricular ejection fraction40 and reduced heart chamber volume, along with weight loss and improved myocardial blood flow
Does The Thyroid Cause Weight Gain
Research Peptides FAQ Purity, Shipping, Storage Frequently asked questions about NovaCell research peptides: purity, COA, HPLC analysis, reconstitution, storage, EU shipping and Research Use Only (RUO) policy
Net income for the quarter rose to $1.61 per share from $1.04 per share a year earlier
When you talk about increasing your portfolio, are you also looking at launching more drugs within the GLP portfolio in India, in addition to Mounjaro and the others